Event Brief
FDA Approves J&J's New Psoriasis Pill
Filed: Mar 18, 2026 at 2:04 PM ET
Summary: Johnson & Johnson's oral psoriasis treatment gains FDA approval, competing with popular injectable options.
WHO: Johnson & Johnson
WHAT: FDA approves psoriasis pill
WHEN: Mar 18, 2026 at 1:17 PM ET
WHERE: USA
WHY: To provide a new oral treatment option for psoriasis patients.
ℹ️ This event is analyzed using pattern arcs, velocity indicators, and source analysis in our MI Console.
Know more. Read less.
The BriefBrief follows the story, so you don't have to read every article. See what happened, how it changed, and where it came from, all in one place.
Same format. Every time.
See how stories unfold →